The treatment of gout.
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000493:Allopurinol / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002749:Chlorprothixene / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy*; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011339:Probenecid / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use; D014528:Uricosuric Agents / Q000627:therapeutic use*; D014747:Vinblastine / Q000627:therapeutic use; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors*
D000305:Adrenal Cortex Hormones; D000700:Analgesics; D014528:Uricosuric Agents; D006118:Griseofulvin; D014747:Vinblastine; D000493:Allopurinol; D002749:Chlorprothixene; D014969:Xanthine Oxidase; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D011339:Probenecid; D001241:Aspirin; D003078:Colchicine; D013442:Sulfinpyrazone; D007213:Indomethacin